Selected research
Industry Research
Pirfenidone Drugs Industry Research Report 2026
Market perspective
The global Pirfenidone Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pirfenidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pirfenidone Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pirfenidone Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pirfenidone Drugs include Teva, Sandoz, Roche, Kawin, Gyre Pharmaceuticals, ScieGen Pharmaceuticals, Apotex, Amneal Pharmaceuticals and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pirfenidone Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pirfenidone Drugs Market by Company
Teva
Sandoz
Roche
Kawin
Gyre Pharmaceuticals
ScieGen Pharmaceuticals
Apotex
Amneal Pharmaceuticals
Accord Healthcare
Pirfenidone Drugs Segment by Type
Capsules
Tablets
Pirfenidone Drugs Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Pirfenidone Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pirfenidone Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pirfenidone Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pirfenidone Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pirfenidone Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pirfenidone Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pirfenidone Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsules
- Tablets
Applications
- Hospital and Clinic
- Retail Pharmacies
- Other
Companies covered
- Teva
- Sandoz
- Roche
- Kawin
- Gyre Pharmaceuticals
- ScieGen Pharmaceuticals
- Apotex
- Amneal Pharmaceuticals
- Accord Healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pirfenidone Drugs Market Size (2021-2032)
- 2.2.2 Global Pirfenidone Drugs Sales (2021-2032)
- 2.2.3 Global Pirfenidone Drugs Market Average Price (2021-2032)
- 2.3 Pirfenidone Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsules
- 2.3.3 Tablets
- 2.4 Pirfenidone Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital and Clinic
- 2.4.3 Retail Pharmacies
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pirfenidone Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pirfenidone Drugs Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Pirfenidone Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Pirfenidone Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Pirfenidone Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pirfenidone Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pirfenidone Drugs, Product Type & Application
- 3.8 Global Manufacturers of Pirfenidone Drugs, Established Date
- 3.9 Global Pirfenidone Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pirfenidone Drugs Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Sandoz
- 4.2.1 Sandoz Company Information
- 4.2.2 Sandoz Business Overview
- 4.2.3 Sandoz Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sandoz Pirfenidone Drugs Product Portfolio
- 4.2.5 Sandoz Recent Developments
- 4.3 Roche
- 4.3.1 Roche Company Information
- 4.3.2 Roche Business Overview
- 4.3.3 Roche Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Roche Pirfenidone Drugs Product Portfolio
- 4.3.5 Roche Recent Developments
- 4.4 Kawin
- 4.4.1 Kawin Company Information
- 4.4.2 Kawin Business Overview
- 4.4.3 Kawin Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Kawin Pirfenidone Drugs Product Portfolio
- 4.4.5 Kawin Recent Developments
- 4.5 Gyre Pharmaceuticals
- 4.5.1 Gyre Pharmaceuticals Company Information
- 4.5.2 Gyre Pharmaceuticals Business Overview
- 4.5.3 Gyre Pharmaceuticals Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Gyre Pharmaceuticals Pirfenidone Drugs Product Portfolio
- 4.5.5 Gyre Pharmaceuticals Recent Developments
- 4.6 ScieGen Pharmaceuticals
- 4.6.1 ScieGen Pharmaceuticals Company Information
- 4.6.2 ScieGen Pharmaceuticals Business Overview
- 4.6.3 ScieGen Pharmaceuticals Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 ScieGen Pharmaceuticals Pirfenidone Drugs Product Portfolio
- 4.6.5 ScieGen Pharmaceuticals Recent Developments
- 4.7 Apotex
- 4.7.1 Apotex Company Information
- 4.7.2 Apotex Business Overview
- 4.7.3 Apotex Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Apotex Pirfenidone Drugs Product Portfolio
- 4.7.5 Apotex Recent Developments
- 4.8 Amneal Pharmaceuticals
- 4.8.1 Amneal Pharmaceuticals Company Information
- 4.8.2 Amneal Pharmaceuticals Business Overview
- 4.8.3 Amneal Pharmaceuticals Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Amneal Pharmaceuticals Pirfenidone Drugs Product Portfolio
- 4.8.5 Amneal Pharmaceuticals Recent Developments
- 4.9 Accord Healthcare
- 4.9.1 Accord Healthcare Company Information
- 4.9.2 Accord Healthcare Business Overview
- 4.9.3 Accord Healthcare Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Accord Healthcare Pirfenidone Drugs Product Portfolio
- 4.9.5 Accord Healthcare Recent Developments
5 Global Pirfenidone Drugs Market Scenario by Region
- 5.1 Global Pirfenidone Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pirfenidone Drugs Sales by Region: 2021-2032
- 5.2.1 Global Pirfenidone Drugs Sales by Region: 2021-2026
- 5.2.2 Global Pirfenidone Drugs Sales by Region: 2027-2032
- 5.3 Global Pirfenidone Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Pirfenidone Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Pirfenidone Drugs Revenue by Region: 2027-2032
- 5.4 North America Pirfenidone Drugs Market Facts & Figures by Country
- 5.4.1 North America Pirfenidone Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pirfenidone Drugs Sales by Country (2021-2032)
- 5.4.3 North America Pirfenidone Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pirfenidone Drugs Market Facts & Figures by Country
- 5.5.1 Europe Pirfenidone Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pirfenidone Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Pirfenidone Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pirfenidone Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pirfenidone Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pirfenidone Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pirfenidone Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pirfenidone Drugs Market Facts & Figures by Country
- 5.7.1 South America Pirfenidone Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pirfenidone Drugs Sales by Country (2021-2032)
- 5.7.3 South America Pirfenidone Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pirfenidone Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pirfenidone Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pirfenidone Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pirfenidone Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pirfenidone Drugs Sales by Type (2021-2032)
- 6.1.1 Global Pirfenidone Drugs Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Pirfenidone Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Pirfenidone Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Pirfenidone Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pirfenidone Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Pirfenidone Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pirfenidone Drugs Sales by Application (2021-2032)
- 7.1.1 Global Pirfenidone Drugs Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Pirfenidone Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Pirfenidone Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Pirfenidone Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pirfenidone Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Pirfenidone Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pirfenidone Drugs Value Chain Analysis
- 8.1.1 Pirfenidone Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pirfenidone Drugs Production Mode & Process
- 8.2 Pirfenidone Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pirfenidone Drugs Distributors
- 8.2.3 Pirfenidone Drugs Customers
9 Global Pirfenidone Drugs Analyzing Market Dynamics
- 9.1 Pirfenidone Drugs Industry Trends
- 9.2 Pirfenidone Drugs Industry Drivers
- 9.3 Pirfenidone Drugs Industry Opportunities and Challenges
- 9.4 Pirfenidone Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst